-
1 Comment
QITIAN Technology Group Co., Ltd is currently in a long term uptrend where the price is trading 52.4% above its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
QITIAN Technology Group Co., Ltd's total revenue rose by 15.8% to $348M since the same quarter in the previous year.
Its net income has increased by 618.3% to $21M since the same quarter in the previous year.
Finally, its free cash flow grew by 1187.5% to $105M since the same quarter in the previous year.
Based on the above factors, QITIAN Technology Group Co., Ltd gets an overall score of 5/5.
| Exchange | SHE |
|---|---|
| ISIN | CNE100000MC6 |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Target Price | 14.71 |
|---|---|
| Beta | 0.48 |
| Market Cap | 7B |
| PE Ratio | None |
| Dividend Yield | None |
QITIAN Technology Group Co., Ltd. develops, produces, and sells plastic lenses in China. The company was founded in 1996 and is based in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300061.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
